Advertisement Worldwide Clinical Trials Receives Recognition From ISR; The CRO to Have on Your “Radar” - Pharmaceutical Business review

Advertisement

Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Worldwide Clinical Trials Receives Recognition From ISR; The CRO to Have on Your “Radar”

"Our data would suggest that if Worldwide Clinical Trials is not on your radar as a potential CRO partner, you should consider some due diligence on them as they were the only CRO with a strong "preference profile" that also had a favorable price perception." Source: ISR 2012 CRO Quality Benchmarking Report

The comprehensive report provides performance scorecards on 25 CROs, based on the interviews of 125 industry professionals, spanning 72 pharmaceutical and biotechnology companies. CROs were assessed across 21 service characteristics determined to be influential in provider selection, loyalty and operational performance. Key highlights of Worldwide Clinical Trials (WCT) performance include:

  • WCT reported "Better Than Most" or "Clear Leadership" ratings in attributes significant to driving operational excellence; project manager quality, team chemistry, timely communication, delivery of clean data and meeting first patient in timeline.
  • WCT was ranked in the top two positions for "Service Provider Loyalty," "Overall Satisfaction with Service Providers," "Willingness to Recommend Service Providers" and "Likelihood to Use Service Providers Again."
  • WCT was one of only two CROs demonstrating no weakness across the 21 attributes analyzed.
  • WCT was recommended to be shortlisted for Companies that require Operational Independence, Low Cost/Value and Global Footprint as mandates in their CRO selection criteria.

Angelico Carta, M.D., President, Worldwide Clinical Trials’, provided thoughtful comment on the report and how its findings support the company’s business philosophy:

"We are very proud of WCT’s performance in this major market research study. We pride ourselves on our operational intelligence and clearly, as the report underscores, our clients are recognizing WCT for the very attributes needed to develop and run clinical trials successfully."

He continued:

"The data around Service Provider Loyalty is remarkable. WCT has long been known for being loyal to our clients and it is fulfilling to learn that our clients are equally loyal and supportive of WCT. Our data would suggest that if Worldwide Clinical Trials is not on your radar as a potential CRO partner, you should consider some due diligence on them as they were the only CRO with a strong "preference profile" that also had a favorable price perception."

"Knowing that a client will continue to use WCT, is satisfied and would recommend us, speaks to what we value most; and what we value most is client satisfaction."